DCF — GOOD SAMARITAN MEDICAL CTR
Enterprise Value: $-103.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-103.5M
Enterprise Value
$-41.5M
PV of Cash Flows
$-62.1M
PV of Terminal Value
$-100.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $323.7M | $-1.7M | -1.0% | $-15.4M | $-14.0M |
| Year 2 | $333.4M | $1.6M | 0.0% | $-12.5M | $-10.4M |
| Year 3 | $343.4M | $5.1M | 1.0% | $-9.5M | $-7.1M |
| Year 4 | $353.7M | $7.0M | 2.0% | $-8.0M | $-5.5M |
| Year 5 | $364.3M | $8.1M | 2.0% | $-7.3M | $-4.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-103.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$314.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.010246312577296844
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5